Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashutosh S Jogalekar

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biopolymers|June 22, 2010
Conformations of stevastelin C3 analogs: computational deconvolution of NMR data reveals conformational heterogeneity and novel motifsAshutosh S Jogalekar
Accountability in Research|July 10, 2015
Social Media, Peer Review, and Responsible Conduct of Research (RCR) in Chemistry: Trends, Pitfalls, and PromisesAshutosh S Jogalekar
Bioorganic & Medicinal Chemistry Letters|September 30, 2010
Identification of optimum computational protocols for modeling the aryl hydrocarbon receptor (AHR) and its interaction with ligandsAshutosh S Jogalekar, Stephan Reiling, Roy J Vaz
Journal of Medicinal Chemistry|November 10, 2009
The discodermolide hairpin structure flows from conformationally stable modular motifsAshutosh S Jogalekar, Frederik H Kriel, Qi Shi, et al.
Biochemistry|September 2, 2008
Cross-strand pairing and amyloid assemblyYan Liang, Sai Venkatesh Pingali, Ashutosh S Jogalekar, et al.
Journal of the American Chemical Society|February 9, 2011
Dictyostatin flexibility bridges conformations in solution and in the β-tubulin taxane binding siteAshutosh S Jogalekar, Krishnan Damodaran, Frederik H Kriel, et al.
Cancer Research|July 30, 2009
The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activitySimak Ali, Dean A Heathcote, Sebastian H B Kroll, et al.
Journal of Medicinal Chemistry|November 18, 2010
A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administrationDean A Heathcote, Hetal Patel, Sebastian H B Kroll, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biopolymers|June 22, 2010
Conformations of stevastelin C3 analogs: computational deconvolution of NMR data reveals conformational heterogeneity and novel motifsAshutosh S Jogalekar
Accountability in Research|July 10, 2015
Social Media, Peer Review, and Responsible Conduct of Research (RCR) in Chemistry: Trends, Pitfalls, and PromisesAshutosh S Jogalekar
Bioorganic & Medicinal Chemistry Letters|September 30, 2010
Identification of optimum computational protocols for modeling the aryl hydrocarbon receptor (AHR) and its interaction with ligandsAshutosh S Jogalekar, Stephan Reiling, Roy J Vaz
Journal of Medicinal Chemistry|November 10, 2009
The discodermolide hairpin structure flows from conformationally stable modular motifsAshutosh S Jogalekar, Frederik H Kriel, Qi Shi, et al.
Biochemistry|September 2, 2008
Cross-strand pairing and amyloid assemblyYan Liang, Sai Venkatesh Pingali, Ashutosh S Jogalekar, et al.
Journal of the American Chemical Society|February 9, 2011
Dictyostatin flexibility bridges conformations in solution and in the β-tubulin taxane binding siteAshutosh S Jogalekar, Krishnan Damodaran, Frederik H Kriel, et al.
Cancer Research|July 30, 2009
The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activitySimak Ali, Dean A Heathcote, Sebastian H B Kroll, et al.
Journal of Medicinal Chemistry|November 18, 2010
A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administrationDean A Heathcote, Hetal Patel, Sebastian H B Kroll, et al.
Pageof 1